Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance? (2021)
Attributed to:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkab189
PubMed Identifier: 34142123
Publication URI: http://europepmc.org/abstract/MED/34142123
Type: Journal Article/Review
Volume: 76
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 9
ISSN: 0305-7453